Pharmaceutical Executive
Pharmaceutical Executive Daily: FDA Approves Lipfendra
July 16 · 3 min · 2.9 MB
0:00-3:02
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
In today's Pharmaceutical Executive Daily, FDA approves Merck's Lipfendra as the first oral PCSK9 inhibitor for high cholesterol, Eli Lilly agrees to acquire AtaiBeckley for up to $3.8 billion, and a Pharmaceutical Executive podcast explores how better questions, not just more data, define strong biopharma leadership.
No links were found in this episode’s notes.